ImmunityBio Files 8-K with Financial Updates
Ticker: IBRX · Form: 8-K · Filed: 2026-04-09T07:39:06-04:00
Sentiment: neutral
Topics: financial-results, 8-k, sec-filing
Related Tickers: IBIO
TL;DR
IBIO dropped an 8-K on 4/9/26 with financial results. Check it out.
AI Summary
ImmunityBio, Inc. filed an 8-K on April 9, 2026, reporting its financial results and condition. The filing includes exhibits such as financial statements and a company logo. The company's mailing and business address is 3530 John Hopkins Court, San Diego, CA 92121.
Why It Matters
This filing provides investors with crucial, up-to-date information on ImmunityBio's financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and exhibits, not indicating any immediate operational or financial distress.
Key Players & Entities
- ImmunityBio, Inc. (company) — Filer of the 8-K report
- 0001326110 (company) — CIK number for ImmunityBio, Inc.
- 2026-04-09 (date) — Filing date and period of report
- 3530 John Hopkins Court, San Diego, CA 92121 (location) — Mailing and business address for ImmunityBio, Inc.
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates Item 2.02: Results of Operations and Financial Condition, but the specific details of the results are not provided in the summary text.
What are the included exhibits with this 8-K filing?
The filing lists EX-99.1 (likely financial statements) and a company logo (IMMUNITYBIO LOGO) as exhibits.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 07:39:06.
What is the CIK number for ImmunityBio, Inc.?
The CIK number for ImmunityBio, Inc. is 0001326110.
What is the business and mailing address for ImmunityBio, Inc.?
The business and mailing address for ImmunityBio, Inc. is 3530 John Hopkins Court, San Diego, CA 92121.
From the Filing
EDGAR Filing Documents for 0001326110-26-000036 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001326110-26-000036 Filing Date 2026-04-09 Accepted 2026-04-09 07:39:06 Documents 13 Period of Report 2026-04-09 Items Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K ibrx-20260409.htm iXBRL 8-K 30407 2 EX-99.1 ibrx-2026498xkexhibit991.htm EX-99.1 20843 6 IMMUNITYBIO LOGO immunitybio-logox2024xcoloa.jpg GRAPHIC 31902 Complete submission text file 0001326110-26-000036.txt 217905 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20260409.xsd EX-101.SCH 1807 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20260409_lab.xml EX-101.LAB 21876 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20260409_pre.xml EX-101.PRE 12528 16 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20260409_htm.xml XML 2718 Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235 ImmunityBio, Inc. (Filer) CIK : 0001326110 (see all company filings) EIN. : 431979754 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 26849833 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)